Long-term study of an experimental drug for stable schizophrenia
Part of Mental health clinical trials.
This trial tests a new medication called SEP-363856 over a long period for people with schizophrenia who are currently stable. It looks at how well the drug works and its safety over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and living in Japan
- You have a diagnosis of schizophrenia and have been stable for at least 8 weeks
- Your symptoms are mild to moderate (a total score of 80 or less on the PANSS scale and a CGI-S score of 4 or less)
- You have not changed your antipsychotic medication in the last 6 weeks
- You have not been in the hospital for psychiatric reasons in the last 8 weeks
- You have not tried multiple antipsychotics that did not work for you, and you have never taken clozapine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing how safe and tolerable an investigational medication is over the long term (52 weeks) when added to your current antipsychotic treatment. It's for people with schizophrenia whose symptoms are stable, and it aims to see if the new medication can help without causing serious side effects.
This study tests a new medicine called NBI-1117568 for adults with schizophrenia over a longer period of time. Participants will stop their current antipsychotics and take this new drug to see how well it works and how safe it is.
This trial tests a new drug, ML-007C-MA, for adults with schizophrenia who may benefit from ongoing treatment. It aims to see how safe and effective the drug is over a longer period.
This study gives healthy men a single dose of a new medication that has a tiny radioactive marker, so researchers can track how it leaves the body through urine and stool. It helps understand how the drug is processed and safe, which is a necessary step before it can be tested in patients.
This trial tests a new medication (HHK101) for people with stable schizophrenia. It aims to see if the drug is safe and how it works in the body. Participants must be on a steady dose of their current antipsychotic.
This trial tests a new medication called LB-102 for people with acute (sudden worsening of) schizophrenia. It aims to see if the drug helps reduce symptoms like hallucinations or disorganized thinking.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.